2. Class members and licensed uses
Consult the summary of product characteristics for details of authorised indications of each SSRI.
SSRIs: Approved names, common proprietary names and licensed indications
(enantiomer of citalopram)
|Common proprietory names||Cipramil||Cipralex||Prozac||Faverin||Seroxat||Lustral|
|Generalised anxiety disorder|
|Panic disorder with or without agoraphobia|
|Social anxiety disorder (social phobia)|
|Post-traumatic stress disorder|
Antidepressants in other classes may also inhibit reuptake of serotonin, but only SSRIs are discussed here.
Only the following SSRIs are licensed for children and adolescents:
- Fluoxetine for the treatment of moderate to severe major depressive episode (in combination with psychological therapy) in children aged over eight years and adolescents
- Fluvoxamine for the treatment of obsessive–compulsive disorder in children aged over eight years and adolescents
- Sertraline for the treatment of obsessive–compulsive disorder in children aged over six years and adolescents.
Page 3 of 29